A Phase 1 Study of TRS005 in Patients With R/R CD20-positive B-NHL.

Clinical trial NCT05395533 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05395533
Sponsor: Zhejiang Teruisi Pharmaceutical Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

CD20-positive B-cell Non-Hodgkin Lymphoma

Start date: 2020-09-08
Primary completion: 2025-07-31
Enrollment: 147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.